A motion expected to be ratified at the upcoming AGM of the National Association of General Practitioners (NAGP) to change the Association’s constitution will allow the body to negotiate immediately with the Department of Health on behalf of Irish GPs, its CEO has said.
Antibacterial resistance is a cause for major concern, according to a leading cystic fibrosis (CF) expert. World-leading CF experts, from Queen’s University Belfast, have called for greater research to address the issue of antibacterial resistance.
Continuing her CPD series from a new online initiative on hypertension, Valerie Ryan hears about the importance of starting from the right place on blood pressure measurement, from a talk by Prof Eoin O’Brien.
Cutting-edge research has been carried out at Queen’s University Belfast into eye disease.
A new initiative is aiming to make personalised medicine available to all European patients. The initiative is led by Prof Mark Lawler, Chair in Translational Cancer Genomics at the Queen’s University Belfast Centre of Cancer Research and Cell Biology (CCRCB).
Dear Editor, My commendations to Dr Patricia Black for her letter (‘Doctors and society cannot ignore the issue of aggressive patients’, IMT 10/10/14). It is on such matters I often wish you had a forum for debate wherein a ‘username’ would dilute the exposure to personal attack.
The HSE will never ‘up its game’ and provide a 21st-Century service until it is challenged to do so by breaking up its failed monopoly once and for all, argues Dr Garret FitzGerald.
Dear Editor, Dr Colm Henry, HSE Clinical Lead for the Clinical Directorate Programme, in an interview (IMT, 29/8/14), highlights that the consultant medical board, an early form of clinical leadership is now passé.